Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI-Powered Robotic Device Identifies Healthcare Outbreaks

By HospiMedica International staff writers
Posted on 27 Jun 2018
A robotic sensing device powered by artificial intelligence (AI) monitors and conveys molecular and environmental data critical to human health and disease control.

The Nano Global (Austin, TX, USA) Nano Bot device features an Arm microcontroller and array of system-on-chip (SoC) environmental sensors that collect ambient environmental parameters. More...
The highly secure data collected by the SoC can then be used to better understand, predict, and rectify health threats caused by pathogens and other living organisms. The information acquired by distinct Nano Bots provides an important data stream to the company’s broader data-driven AI platform, which is called Nano Sense.

The Soc leverages advances in nanotechnology optics (including both microscopy and spectroscopy); Cortex-A edge computing processors and Arm Mali graphics processing units (GPUs) to enable highly-optimized, local processing and analysis of molecular data and relevant parameters in real time; AI, including machine learning and vision, so as to help identify patterns of molecular data; and blockchain authentication technology, which is utilized as a fundamental architectural element supporting data attribution, privacy, and security, as well as economic mechanisms.

“Implementing this technology in healthcare facilities aligns perfectly with our mission to provide the best care for patients while furthering important research to better understand how our environment creates and contributes to health threats,” said Peter Hotez, MD, PhD, professor of pediatrics and molecular virology & microbiology at Baylor College of Medicine (Houston, TX, USA), director of Texas Children’s Hospital Center for Vaccine Development, and U.S. Science Envoy.

“For Nano and its affiliates, the release of our first-generation Nano Bot device signals an important step in our mission to help fight global health threats,” said Steve Papermaster, chairman and CEO of Nano Global. “We believe our technology platform is a game-changer for detecting and understanding critical elements of health, and look forward to building on this exciting momentum.”

“We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology,” said Rene Haas, executive vice president and president of Arm. “By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges.”

Related Links:
Nano Global
Baylor College of Medicine


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.